Reference data : LOINC code

Filter


Clear filter

Results
108,248 results found
Loinc Number Component Property System Time aspect ScaleType MethodType Relat_nms loincStatus Long Common name answerList chngType <span class='defaultText'>DefinitionDescription</span> dtLastCh exactCmspy exampleUnits exmplAnswers externalCopyrightNotice formula hl7FieldSubfieldId InpcPercentage ipccUnits loincClass loincFinal loincNum mapTo methodTyp molarMass naaccrId orderObs panelElements reference scope setRoot shortName source surveyQuestSrc surveyQuestText unitsRequired acssym relatedNames2 VersionLastChanged VersionFirstRelease ValidHL7AttachmentRequest PanelType AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
98938-4 Satisfaction with sex life in last 2W Find ^Patient 2W Ord &nbsp; &nbsp; ACTIVE Satisfaction with sex life in last 2 weeks &nbsp; ADD DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; SURVEY.GNHLTH &nbsp; 98938-4 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 &nbsp; &nbsp; &nbsp; &nbsp; N &nbsp; 14 days; 2 weeks; Finding; Findings; Gender; Ordinal; Past; QL; Qual; Qualitative; Satisfact w/sex life last 2W; Screen; Survey; SURVEY.GNHLTH 2.72 2.72 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
98939-2 Satisfaction with support from friends in last 2W Find ^Patient 2W Ord &nbsp; &nbsp; ACTIVE Satisfaction with support from friends in last 2 weeks &nbsp; ADD DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; SURVEY.GNHLTH &nbsp; 98939-2 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 &nbsp; &nbsp; &nbsp; &nbsp; N &nbsp; 14 days; 2 weeks; Finding; Findings; Ordinal; Past; QL; Qual; Qualitative; Satisf w/support from friends last 2W; Screen; Survey; SURVEY.GNHLTH 2.72 2.72 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
9894-7 P wave amplitude.lead III Elpot Heart Pt Qn EKG &nbsp; ACTIVE P wave amplitude in lead III &nbsp; MIN DefinitionDescription &nbsp; &nbsp; mV &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; EKG.MEAS &nbsp; 9894-7 &nbsp; EKG &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 P wave Amp L-III &nbsp; &nbsp; &nbsp; Y &nbsp; 3; Cardiac; Cardio; Cardiology; ECG; EKG.MEASUREMENTS; Electrical potential; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; P prime; P' wave Amp L-III; P wave Amp L-III; Painter's colic; PB; Plumbism; Point in time; QNT; Quan; Quant; Quantitative; Random; Voltage 2.48 1.0i &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; mV &nbsp; &nbsp; &nbsp; 0
98940-0 Satisfaction with condition of living place in last 2W Find ^Patient 2W Ord &nbsp; &nbsp; ACTIVE Satisfaction with condition of living place in last 2 weeks &nbsp; ADD DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; SURVEY.GNHLTH &nbsp; 98940-0 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 &nbsp; &nbsp; &nbsp; &nbsp; N &nbsp; 14 days; 2 weeks; Finding; Findings; Ordinal; Past; QL; Qual; Qualitative; Satisf w/cond of living place last 2W; Screen; Survey; SURVEY.GNHLTH 2.72 2.72 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
98941-8 Satisfaction with access to health services in last 2W Find ^Patient 2W Ord &nbsp; &nbsp; ACTIVE Satisfaction with access to health services in last 2 weeks &nbsp; ADD DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; SURVEY.GNHLTH &nbsp; 98941-8 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 &nbsp; &nbsp; &nbsp; &nbsp; N &nbsp; 14 days; 2 weeks; Finding; Findings; Ordinal; Past; QL; Qual; Qualitative; Satisf access to health services last 2W; Screen; Survey; SURVEY.GNHLTH 2.72 2.72 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
98942-6 Satisfaction with access to transportation in last 2W Find ^Patient 2W Ord &nbsp; &nbsp; ACTIVE Satisfaction with access to transportation in last 2 weeks &nbsp; ADD DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; SURVEY.GNHLTH &nbsp; 98942-6 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 &nbsp; &nbsp; &nbsp; &nbsp; N &nbsp; 14 days; 2 weeks; Finding; Findings; Ordinal; Past; QL; Qual; Qualitative; Satisf access transportation last 2W; Screen; Survey; SURVEY.GNHLTH 2.72 2.72 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
98943-4 Frequency of negative feelings in last 2W Find ^Patient 2W Ord &nbsp; &nbsp; ACTIVE Frequency of negative feelings in last 2 weeks &nbsp; ADD DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; SURVEY.GNHLTH &nbsp; 98943-4 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 &nbsp; &nbsp; &nbsp; &nbsp; N &nbsp; 14 days; 2 weeks; Finding; Findings; Freq of negative feelings last 2W; NEG; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH 2.72 2.72 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
98944-2 Total Score Score ^Patient 2W Qn WHOQOL_BREF &nbsp; ACTIVE Total score [WHOQOL_BREF] &nbsp; ADD DefinitionDescription &nbsp; &nbsp; score &nbsp; Reproduced with permission from WHOQOL-BREF Field Trial Version, Geneva, World Health Organization (WHO), 1996, https://www.who.int/publications/i/item/WHOQOL-BREF, accessed Sep 2021. WHO does not endorse any specific companies, products or services. &nbsp; &nbsp; &nbsp; &nbsp; SURVEY.GNHLTH &nbsp; 98944-2 &nbsp; WHOQOL_BREF &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 &nbsp; &nbsp; &nbsp; &nbsp; N &nbsp; 14 days; 2 weeks; QNT; Quan; Quant; Quantitative; Scale; Survey; SURVEY.GNHLTH; Tot; Totl 2.72 2.72 &nbsp; &nbsp; &nbsp; &nbsp; Reproduced with permission from WHOQOL-BREF Field Trial Version, Geneva, World Health Organization (WHO), 1996, https://www.who.int/publications/i/item/WHOQOL-BREF, accessed Sep 2021. WHO does not endorse any specific companies, products or services. &nbsp; &nbsp; {score} &nbsp; &nbsp; &nbsp; 0
98945-9 Hip disability and osteoarthritis outcome score - physical function shortform panel - ^Patient Pt - HOOS-PS &nbsp; ACTIVE Hip disability and osteoarthritis outcome score - physical function shortform panel [HOOS-PS] &nbsp; ADD DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; Copyright �© 2012 Ewa Roos. Used with permission. &nbsp; &nbsp; &nbsp; &nbsp; PANEL.SURVEY.GNHLTH &nbsp; 98945-9 &nbsp; HOOS-PS &nbsp; &nbsp; Order &nbsp; &nbsp; &nbsp; 0 &nbsp; &nbsp; &nbsp; &nbsp; N &nbsp; FCN; Func; Funct; Hip dysfunction and Osteoarthritis Outcome Score; HOOS JR; Lower extremity joint; Pan; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH 2.72 2.72 &nbsp; Panel &nbsp; &nbsp; Copyright �© 2012 Ewa Roos. Used with permission. &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
98946-7 Total score Score ^Patient Pt Qn HOOS-PS &nbsp; ACTIVE Total score [HOOS-PS] &nbsp; ADD DefinitionDescription &nbsp; &nbsp; score &nbsp; Copyright �© 2012 Ewa Roos. Used with permission. &nbsp; &nbsp; &nbsp; &nbsp; SURVEY.GNHLTH &nbsp; 98946-7 &nbsp; HOOS-PS &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 &nbsp; &nbsp; &nbsp; &nbsp; N &nbsp; Hip dysfunction and Osteoarthritis Outcome Score; HOOS JR; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.GNHLTH; Tot; Totl 2.72 2.72 &nbsp; &nbsp; &nbsp; &nbsp; Copyright �© 2012 Ewa Roos. Used with permission. &nbsp; &nbsp; {score} &nbsp; &nbsp; &nbsp; 0
98947-5 SARS-CoV-2-related socioeconomic questionnaire for school-age children intake questions - ^Patient Pt - &nbsp; &nbsp; ACTIVE SARS-CoV-2-related socioeconomic questionnaire for school-age children intake questions &nbsp; ADD DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; PANEL.SURVEY.COVID &nbsp; 98947-5 &nbsp; &nbsp; &nbsp; &nbsp; Subset &nbsp; &nbsp; &nbsp; 0 &nbsp; &nbsp; &nbsp; &nbsp; N &nbsp; CoV-2 SocEcon - children intake; CoV-2 SocEcon - school-age children; II; Pan; Panel; Panl; Pnl; Point in time; Random; Severe Acute Respiratory Syndrome; Survey 2.72 2.72 &nbsp; Organizer &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
98948-3 SARS-CoV-2-related socioeconomic questionnaire for school-age children 12Mo follow-up - ^Patient 12Mo - &nbsp; &nbsp; ACTIVE SARS-CoV-2-related socioeconomic questionnaire for school-age children 12 month follow-up &nbsp; ADD DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; PANEL.SURVEY.COVID &nbsp; 98948-3 &nbsp; &nbsp; &nbsp; &nbsp; Subset &nbsp; &nbsp; &nbsp; 0 &nbsp; &nbsp; &nbsp; &nbsp; N &nbsp; 1 year; 12Mos; CoV-2 SocEcon - children 12Mo; CoV-2 SocEcon - school-age children; II; Pan; Panel; Panl; Pnl; Severe Acute Respiratory Syndrome; Survey 2.72 2.72 &nbsp; Organizer &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
98949-1 Were classes suspended in last 12Mo Find ^Patient 12Mo Ord &nbsp; &nbsp; ACTIVE Were classes suspended in last 12 months &nbsp; ADD DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; SURVEY.COVID &nbsp; 98949-1 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 &nbsp; &nbsp; &nbsp; &nbsp; N &nbsp; 1 year; 12Mos; Finding; Findings; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; Were classes suspended last 12Mo 2.72 2.72 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
9895-4 P wave amplitude.lead V1 Elpot Heart Pt Qn EKG &nbsp; ACTIVE P wave amplitude in lead V1 &nbsp; MIN DefinitionDescription &nbsp; &nbsp; mV &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; EKG.MEAS &nbsp; 9895-4 &nbsp; EKG &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 P wave Amp L-V1 &nbsp; &nbsp; &nbsp; Y &nbsp; Cardiac; Cardio; Cardiology; ECG; EKG.MEASUREMENTS; Electrical potential; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; P prime; P' wave Amp L-V1; P wave Amp L-V1; Painter's colic; PB; Plumbism; Point in time; QNT; Quan; Quant; Quantitative; Random; Voltage 2.48 1.0i &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; mV &nbsp; &nbsp; &nbsp; 0
98950-9 How long were classes suspended in last 12Mo Time ^Patient 12Mo Qn &nbsp; &nbsp; ACTIVE How long were classes suspended in last 12 months &nbsp; ADD DefinitionDescription &nbsp; &nbsp; wk &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; SURVEY.COVID &nbsp; 98950-9 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 &nbsp; &nbsp; &nbsp; &nbsp; N &nbsp; 1 year; 12Mos; How long classes suspended; How long classes suspended last 12Mo; Past; QNT; Quan; Quant; Quantitative; Survey; Were classes suspended last 12Mo 2.72 2.72 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; wk &nbsp; &nbsp; &nbsp; 0
98951-7 Amount of school lost in last 12Mo Time ^Patient 12Mo Qn &nbsp; &nbsp; ACTIVE Amount of school lost in last 12 months &nbsp; ADD DefinitionDescription &nbsp; &nbsp; wk &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; SURVEY.COVID &nbsp; 98951-7 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 &nbsp; &nbsp; &nbsp; &nbsp; N &nbsp; 1 year; 12Mos; Amt of school lost; Amt of school lost in last 12Mo; Past; QNT; Quan; Quant; Quantitative; Survey 2.72 2.72 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; wk &nbsp; &nbsp; &nbsp; 0
98952-5 Reason for not participating in remote learning in last 12Mo Find ^Patient 12Mo Nom &nbsp; &nbsp; ACTIVE Reason for not participating in remote learning in last 12 months &nbsp; ADD DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; SURVEY.COVID &nbsp; 98952-5 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 &nbsp; &nbsp; &nbsp; &nbsp; N &nbsp; 1 year; 12Mos; Finding; Findings; Nominal; Past; Reason not partic remote learn last 12Mo; Reason not participate remote learning; Survey 2.72 2.72 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
98953-3 Able to participate in remote learning in last 12Mo Find ^Patient 12Mo Ord &nbsp; &nbsp; ACTIVE Able to participate in remote learning in last 12 months &nbsp; ADD DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; SURVEY.COVID &nbsp; 98953-3 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 &nbsp; &nbsp; &nbsp; &nbsp; N &nbsp; 1 year; 12Mos; Able to partic remote learn last 12Mo; Finding; Findings; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey 2.72 2.72 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
98954-1 KCNN4 gene full mutation analysis Find Bld/Tiss Pt Doc Sequencing &nbsp; ACTIVE KCNN4 gene full mutation analysis in Blood or Tissue by Sequencing &nbsp; ADD DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; MOLPATH &nbsp; 98954-1 &nbsp; Sequencing &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 KCNN4 gene Full Mut Anl Bld/T Seq &nbsp; &nbsp; &nbsp; N &nbsp; Blood; Document; Finding; Findings; full gene sequencing; Full Mut Anl; high-throughput sequencing; HTS; Molecular pathology; MOLPATH; Mut; Mutations; Next generation sequencing; NGS; Point in time; Random; sequencing of entire coding region; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue 2.72 2.72 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
98955-8 Burkholderia pseudomallei Ab Titr XXX Pt SemiQn HAI &nbsp; ACTIVE Burkholderia pseudomallei Ab [Titer] in Specimen by Hemagglutination inhibition &nbsp; MAJ DefinitionDescription &nbsp; &nbsp; titer &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; MICRO &nbsp; 98955-8 &nbsp; HAI &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 B pseudomal Ab Titr Spec HAI &nbsp; &nbsp; &nbsp; N &nbsp; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B pseudomal; B pseudomallei; Dilution factor; Dilution Factor (Titer); HEMAGGLUTINATION INHIBITION; HI; Melioidosis; Microbiology; Misc; Miscellaneous; Other; Point in time; Pseudomonas pseudomallei; Random; SmQn; Spec; Titer; Titered; Titre; To be specified in another part of the message; Ttr; Unspecified 2.75 2.72 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; {titer} &nbsp; &nbsp; &nbsp; 0
98956-6 Coccidioides immitis Ab.IgM ACnc XXX Pt Qn IA &nbsp; ACTIVE Coccidioides immitis IgM Ab [Units/volume] in Specimen by Immunoassay &nbsp; ADD DefinitionDescription &nbsp; &nbsp; arb U/mL &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; MICRO &nbsp; 98956-6 &nbsp; IA &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 C immitis IgM Spec IA-aCnc &nbsp; &nbsp; &nbsp; N &nbsp; ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; B immitis; Blastomycoides immitis; C esteriformis; C immitis; Coccidioides esteriformis; Coccidiomycosis; Coccio; EIA; ELFA; ELISA; Enzyme immunoassay; G immite; G louisianoideum; G metaeuropea; Geotrichum immite; Glenospora metaeuropea; Glenosporum louisianoideum; IAA; Immune globulin M; Immunoglobulin M; MEIA; Microbiology; Misc; Miscellaneous; Other; P esteriformis; P mazzai; Point in time; Posadasia esteriformis; Pseudococcidioides mazzai; QNT; Quan; Quant; Quantitative; Random; San Joaquin Valley fever; Spec; SUDS; T proteolyticum; To be specified in another part of the message; Trichosporon proteolyticum; Unspecified; Valley fever 2.72 2.72 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; [arb'U]/mL &nbsp; &nbsp; &nbsp; 0
98957-4 Coccidioides immitis Ab.IgG ACnc XXX Pt Qn IA &nbsp; ACTIVE Coccidioides immitis IgG Ab [Units/volume] in Specimen by Immunoassay &nbsp; ADD DefinitionDescription &nbsp; &nbsp; arb U/mL &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; MICRO &nbsp; 98957-4 &nbsp; IA &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 C immitis IgG Spec IA-aCnc &nbsp; &nbsp; &nbsp; N &nbsp; ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; B immitis; Blastomycoides immitis; C esteriformis; C immitis; Coccidioides esteriformis; Coccidiomycosis; Coccio; EIA; ELFA; ELISA; Enzyme immunoassay; G immite; G louisianoideum; G metaeuropea; Geotrichum immite; Glenospora metaeuropea; Glenosporum louisianoideum; IAA; Immune globulin G; Immunoglobulin G; MEIA; Microbiology; Misc; Miscellaneous; Other; P esteriformis; P mazzai; Point in time; Posadasia esteriformis; Pseudococcidioides mazzai; QNT; Quan; Quant; Quantitative; Random; San Joaquin Valley fever; Spec; SUDS; T proteolyticum; To be specified in another part of the message; Trichosporon proteolyticum; Unspecified; Valley fever 2.72 2.72 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; [arb'U]/mL &nbsp; &nbsp; &nbsp; 0
98958-2 Periostin SCnc Ser/Plas Pt Qn IA &nbsp; ACTIVE Periostin [Moles/volume] in Serum or Plasma by Immunoassay &nbsp; ADD DefinitionDescription &nbsp; &nbsp; pmol/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 98958-2 &nbsp; IA &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Periostin SerPl IA-sCnc &nbsp; &nbsp; &nbsp; N &nbsp; Chemistry; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Level; MEIA; OSF-2; osteoblast-specific factor; Pl; Plasma; Plsm; Point in time; POSTN; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; SUDS 2.72 2.72 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; pmol/L &nbsp; &nbsp; &nbsp; 0
98959-0 Aspergillus fumigatus PrThr Isolate Pt Ord MS.MALDI-TOF &nbsp; ACTIVE Aspergillus fumigatus [Presence] in Isolate by MS.MALDI-TOF &nbsp; ADD DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; MICRO &nbsp; 98959-0 &nbsp; MS.MALDI-TOF &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 A fumigatus Islt Ql MS.MALDI-TOF &nbsp; &nbsp; &nbsp; N &nbsp; A fumigatus; Asperg; Aspergil; Aspergilis; Aspergilla; Aspergillin; Aspergillosis; Aspergils; Aspergilus; Farmers lung; Fum; Islt; Isol; m003; m3; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen 2.72 2.72 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
9896-2 P wave amplitude.lead V2 Elpot Heart Pt Qn EKG &nbsp; ACTIVE P wave amplitude in lead V2 &nbsp; MIN DefinitionDescription &nbsp; &nbsp; mV &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; EKG.MEAS &nbsp; 9896-2 &nbsp; EKG &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 P wave Amp L-V2 &nbsp; &nbsp; &nbsp; Y &nbsp; Cardiac; Cardio; Cardiology; ECG; EKG.MEASUREMENTS; Electrical potential; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; P prime; P' wave Amp L-V2; P wave Amp L-V2; Painter's colic; PB; Plumbism; Point in time; QNT; Quan; Quant; Quantitative; Random; Voltage 2.48 1.0i &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; mV &nbsp; &nbsp; &nbsp; 0
108,248 results found